CPT code 17264 represents destruction of a malignant skin lesion on the trunk, arms, or legs measuring 3.1 cm to 4.0 cm in diameter using methods such as chemosurgery, cryosurgery, electrosurgery, or other destructive techniques. This procedural code captures a distinct size tier for lesion destruction and is important for accurate clinical documentation, proper claims processing, and national utilization tracking of dermatologic oncologic procedures.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Coverage, coding guidance, and payment rates for lesion destruction procedures can vary across commercial plans and Medicare fee schedules, making precise code selection and documentation essential for reimbursement and quality reporting.

Readers will find an overview of the clinical context for lesion destruction, the service and typical sites of service, and what to expect in payer coverage and coding practice. The publication provides benchmark context, coding considerations related to lesion size and technique, and an outline of common modifiers (Data not available in the input for payer-specific rates and detailed policy variations). This national-level summary aids clinicians, billing staff, and policy analysts in understanding how CPT code 17264 fits into procedural coding workflows and payer interactions.